Development of a personalized infusion failure detection algorithm combining tissue counter pressure and blood glucose data for closed-loop diabetes management
开发结合组织反压和血糖数据的个性化输注失败检测算法,用于闭环糖尿病管理
基本信息
- 批准号:10296116
- 负责人:
- 金额:$ 30万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2022-12-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAddressAdhesionsAffectAlgorithmsAngiographyArtificial PancreasBlood CirculationBlood GlucoseBolus InfusionCannulasCaringCessation of lifeCharacteristicsClinical DataCollectionComplexComputer softwareDataDatabasesDepositionDetectionDevelopmentDiabetes MellitusDiabetic KetoacidosisDiagnostic radiologic examinationDiffusionEnsureEquipmentExerciseFailureFamily suidaeGlucoseGoalsHealthHospital CostsHourHyperglycemiaImageImmobilizationInfectionInfusion PumpsInfusion proceduresInjuryInsulinInsulin Infusion SystemsInsulin-Dependent Diabetes MellitusLabelLeadLifeLife StyleLiquid substanceMachine LearningMeasuresMedical Care CostsMedical DeviceMethodsMicrofluidicsMiniature SwineModelingModernizationMonitorNoisePatientsPerformancePharmaceutical PreparationsPhasePhysiologyPreventionPumpQuality of lifeRecommendationReportingResearchResistanceRiskSafetySkinSmall Business Innovation Research GrantSourceSpecimenSymptomsSystemTechnologyTestingTimeTissuesTrainingUpdateVisionWorkbasecostdesigndiabetes managementdiabeticexperiencefield studyfluid flowglucose monitorglycemic controlimprovedin vivoirritationmachine learning methodnovelpre-clinicalpressurepreventprototypesensorsubcutaneous
项目摘要
PROJECT SUMMARY/ABSTRACT
Advances in diabetes care technology over the past several decades, including improvements in continuous
subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM), have led to more streamlined
treatments and reduced burden for patients with type 1 diabetes (T1D). As the field moves toward increasingly
autonomous, closed-loop systems for management of T1D, infusion set failure (ISF) remains a health risk to
patients and a barrier to the development of artificial pancreas systems. ISF, the disruption of fluid flow from
insulin pump to patient causing loss of glycemic control, affects an estimated 50% of pump wearers, placing
them at risk for hyperglycemia and life-threatening complications such as diabetic ketoacidosis. Because modern
insulin pumps are not equipped with a mechanism for monitoring infusion performance, patients may not know
an ISF has occurred until experiencing symptoms of hyperglycemia. There is no existing technology capable of
accurately identifying ISF in real-time, before dysregulation of blood glucose (BG).
Diatech Diabetes is addressing this unmet need with SmartFusion, an AI-based platform to monitor infusion
performance, immediately alert patients when ISF occurs, and help users infuse confidently and safely. Diatech’s
novel algorithm leverages tissue counter pressure (TCP) and CGM data to offer a superior method for ISF
detection. The company’s long-term vision is that by detecting ISF in real time, SmartFusion will improve patients’
glycemic control, prevent complications of hyperglycemia, and reduce excess medical costs. Diatech has already
collected preliminary data to show that TCP waveforms can feasibly be leveraged to differentiate healthy and
malfunctioned infusions. The goal of this Phase I SBIR proposal is to collect increasingly complex and
representative preclinical data to train and optimize the TCP-CGM algorithm and demonstrate proof-of-concept
that it can accurately detect ISF. Diatech will pursue this goal through the following aims: 1) collect and
characterize labeled in vivo TCP and x-ray imaging data of typical and malfunctioned infusions, 2) collect and
characterize labeled in vivo TCP and BG/CGM data of failure modes consistent with ISF in immobilized diabetic
swine, and 3) collect 3-day TCP and BG/CGM data from ambulatory diabetic swine with failure modes consistent
with ISF.
Successful completion of the project will result in a novel TCP-CGM algorithm to accurately detect ISF in closed-
loop systems. The algorithm will be further optimized through collection and integration of clinical data in Phase
II. SmartFusion will ultimately be integrated into insulin pumps and diabetes management platforms to provide
real-time ISF detection and personalized recommendations for ISF prevention. Further, by enabling new
avenues for control of closed-loop systems, SmartFusion can offer a significant leap forward for implementation
of artificial pancreas technology, leading to improved health and quality of life for patients living with T1D.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Clark Gray其他文献
John Clark Gray的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 30万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 30万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 30万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 30万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 30万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 30万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 30万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 30万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 30万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 30万 - 项目类别:
Research Grant